Cytori Therapeutics (CYTX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Join SI Premium – FREE
Cytori Therapeutics (NASDAQ: CYTX) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nike (NKE) Tops Q1 EPS by 4c
- Bernstein SocGen Group Starts Forgent Power Solutions (FPS) at Outperform
- Roth/MKM Starts Suja Life Inc. (SUJA) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
